Most cited medicine papers
- Verified
Cysteine proteinase SpeB from Streptococcus pyogenes – a potent modifier of immunologically important host and bacterial proteins
Nelson, D. C., Garbe, J., & Collin, M. (2011) · bchm
Streptococcal Infections and TreatmentsBiochemical and Structural Characterization
Cited by 160
- Verified
Remote home monitoring (virtual wards) for confirmed or suspected COVID-19 patients: a rapid systematic review
Vindrola-Padros, C., Singh, K. E., Sidhu, M. S., Georghiou, T., Sherlaw-Johnson, C., Tomini, S. M., Inada-Kim, M., Kirkham, K., Streetly, A., Cohen, N., et al. (2021) · eClinicalMedicine
Telemedicine and Telehealth ImplementationCOVID-19 Clinical Research Studies
Cited by 160
- Verified
Biomarkers of Cardiovascular Disease as Risk Factors for Age-Related Macular Degeneration
Vine, A. K., Stader, J., Branham, K., Musch, D. C., & Swaroop, A. (2005) · Ophthalmology
Retinal Diseases and TreatmentsOcular Diseases and Behçet’s Syndrome
Cited by 160
- Verified
Ultrasound-guidance vs. standard technique in difficult vascular access patients by ed technicians
Bauman, M., Braude, D., & Crandall, C. (2009) · The American Journal of Emergency Medicine
Central Venous Catheters and HemodialysisVascular Procedures and Complications
Cited by 160
- Verified
Increased epithelial uptake of protein antigens in the ileum of Crohn’s disease mediated by tumour necrosis factor α
Söderholm, J. D., Streutker, C., Yang, P.-C., Paterson, C., Singh, P. K., McKay, D. M., Sherman, P. M., Croitoru, K., & Perdue, M. H. (2004) · Gut
Inflammatory Bowel DiseaseOcular Diseases and Behçet’s Syndrome
Cited by 160
- Verified
CBT for People with Intellectual Disabilities: Emerging Evidence, Cognitive Ability and IQ Effects
Taylor, J. L., Lindsay, W. R., & Willner, P. (2008) · Behavioural and Cognitive Psychotherapy
Down syndrome and intellectual disability researchBehavioral and Psychological Studies
Cited by 160
- Verified
The dark side of opioids in pain management: basic science explains clinical observation
Rivat, C., & Ballantyne, J. (2016) · PAIN Reports
Pain Management and Opioid UsePain Mechanisms and Treatments
Cited by 160
- Verified
Dopamine and psychosis: Theory, pathomechanisms and intermediate phenotypes
Tost, H., Alam, T., & Meyer-Lindenberg, A. (2010) · Neuroscience & Biobehavioral Reviews
Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior
Cited by 160
- Verified
Global prevalence of social isolation among community-dwelling older adults: a systematic review and meta-analysis
Teo, R. H., Cheng, W. H., Cheng, L. J., Lau, Y., & Lau, S. T. (2023) · Archives of Gerontology and Geriatrics
Aging, Health, and DisabilityHealth disparities and outcomes
Cited by 160
- Verified
A placebo-controlled trial of continuous intravenous diltiazem infusion for 24-hour heart rate control during atrial fibrillation and atrial flutter: a multicenter study
Ellenbogen, K. A., Dias, V. C., Plumb, V. J., Heywood, J. T., & Mirvis, D. M. (1991) · Journal of the American College of Cardiology
Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and Treatments
Cited by 160
- Verified
Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naïve rats and in rat models of inflammatory and neuropathic pain
Elmes, S. J. R., Jhaveri, M. D., Smart, D., Kendall, D. A., & Chapman, V. (2004) · European Journal of Neuroscience
Pain Mechanisms and TreatmentsCannabis and Cannabinoid Research
Cited by 160
- Verified
Exercise training response heterogeneity: physiological and molecular insights.
Sparks, L. M. (2017) · Diabetologia
Cardiovascular and exercise physiologyGenetics and Physical Performance
Cited by 160
- Verified
Temporal and spatial trend analysis of all-cause depression burden based on Global Burden of Disease (GBD) 2019 study
Liu, J., Liu, Y., Ma, W., Tong, Y., & Zheng, J. (2024) · Scientific Reports
Mental Health Treatment and AccessTreatment of Major Depression
Cited by 160
- Verified
Exercise as treatment for alcohol use disorders: systematic review and meta-analysis
Hallgren, M., Vancampfort, D., Giesen, E. S., Lundin, A., & Stubbs, B. (2017) · British Journal of Sports Medicine
Substance Abuse Treatment and OutcomesPhysical Activity and Health
Cited by 160
- Verified
Differences of behavioral and psychological symptoms of dementia in disease severity in four major dementias
Kazui, H., Yoshiyama, K., Kanemoto, H., Suzuki, Y., Sato, S., Hashimoto, M., Ikeda, M., Tanaka, H., Hatada, Y., Matsushita, M., et al. (2016) · PLOS ONE
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 160
- Verified
Oral Octreotide Absorption in Human Subjects: Comparable Pharmacokinetics to Parenteral Octreotide and Effective Growth Hormone Suppression
Tuvia, S., Atsmon, J., Teichman, S. L., Katz, S., Salama, P., Pelled, D., Landau, I., Karmeli, I., Bidlingmaier, M., Strasburger, C. J., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism
Growth Hormone and Insulin-like Growth FactorsPituitary Gland Disorders and Treatments
Cited by 160
- Verified
Infant mortality due to perinatal causes in Brazil: trends, regional patterns and possible interventions
Victora, C. G., & Barros, F. C. (2001) · Sao Paulo Medical Journal
Global Maternal and Child HealthMaternal and Neonatal Healthcare
Cited by 160
- Verified
ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials
Wang, J., Logovinsky, V., Hendrix, S. B., Stanworth, S. H., Perdomo, C., Xu, L., Dhadda, S., Do, I., Rabe, M., Luthman, J., et al. (2016) · Journal of Neurology, Neurosurgery & Psychiatry
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 160
- Verified
Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders?
Sanacora, G., & Schatzberg, A. F. (2015) · Neuropsychopharmacology
Treatment of Major DepressionElectroconvulsive Therapy Studies
Cited by 160
- Verified
Clinically and pharmacologically relevant interactions of antidiabetic drugs
May, M., & Schindler, C. (2016) · Therapeutic Advances in Endocrinology and Metabolism
Diabetes Treatment and ManagementPharmacogenetics and Drug Metabolism
Cited by 160
- Verified
Fetal syphilis: clinical and laboratory characteristics
Hollier, L. (2001) · Obstetrics & Gynecology
Syphilis Diagnosis and TreatmentNeonatal and Maternal Infections
Cited by 160
- Verified
KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancer
Krall, E. B., Wang, B., Munoz, D. M., Ilic, N., Raghavan, S., Niederst, M. J., Yu, K., Ruddy, D. A., Aguirre, A. J., Kim, J. W., et al. (2017) · eLife
Lung Cancer Treatments and MutationsGenomics, phytochemicals, and oxidative stress
Cited by 160
- Verified
Use of artificial intelligence in critical care: opportunities and obstacles
Pinsky, M. R., Bedoya, A., Bihorac, A., Celi, L., Churpek, M., Economou-Zavlanos, N. J., Elbers, P., Saria, S., Liu, V., Lyons, P. G., et al. (2024) · Critical Care
Artificial Intelligence in Healthcare and EducationMachine Learning in Healthcare
Cited by 160
- Verified
Psychostimulants as cognitive enhancers: The prefrontal cortex, catecholamines, and attention-deficit/hyperactivity disorder
Berridge, C. W., & Devilbiss, D. M. (2011) · Biological Psychiatry
Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on Behavior
Cited by 160
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free